Novellia raises $18M to scale patient-controlled medical data platform
Novellia secures $18 million to empower patients and accelerate pharmaceutical research through data sharing
Patient-controlled health data startup Novellia Inc. today announced it has raised $18 million in Series A funding to scale up a platform that lets patients consolidate their medical records and choose to share them with drug companies for research. The company also announced the...
SiliconANGLE
Source
Generated insight by OnAirToday AI
Novellia is leveraging patient-controlled data to accelerate medical research by creating a streamlined, ethical pipeline for pharmaceutical companies. By putting the user in charge of their sensitive health records, the platform addresses major privacy concerns while providing high-quality datasets for AI-driven drug development.
Comments
Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.